Thomas Desrosier's Net Worth
$3.8 Million
Who is Thomas Desrosier?
Thomas Desrosier has an estimated net worth of $3.8 Million. This is based on reported shares across multiple companies, which include GENZYME CORP, Seres Therapeutics, Inc., ARIAD PHARMACEUTICALS INC, and CUBIST PHARMACEUTICALS INC.
SEC CIK
Thomas Desrosier's CIK is 0001435744
Past Insider Trading and Trends
2014 was Thomas Desrosier's most active year for acquiring shares with 11 total transactions. Thomas Desrosier's most active month to acquire stocks was the month of January. 2011 was Thomas Desrosier's most active year for disposing of shares, totalling 17 transactions. Thomas Desrosier's most active month to dispose stocks was the month of March. 2010 saw Thomas Desrosier paying a total of $1,186,917.76 for 28,871 shares, this is the most they've acquired in one year. In 2011 Thomas Desrosier cashed out on 224,430 shares for a total of $12,333,384.76, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GENZYME CORP No price found
Sr VP, General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -12.24K |
$74.00 | -$1,747,732.00 |
0
|
Apr 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| +265.36% | 3.86K |
$45.60 | -$89,923.20 | 5.32K |
May 24 - May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
∞
| 3.77K |
$52.10 | $196,513.66 | 3.77K |
Apr 23
| |||
Form 4
|
—
|
0
|
$78.99 | -$847,167.75 | 716 |
Aug 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Seres Therapeutics, Inc. (MCRB) Snapshot price: $1.035
Chief Legal Officer and EVP
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.50% | 1.81K |
$0.94 | -$792.42 | 122.39K |
May 15
| |||
Form 4
| +5.87% | 6.69K |
$1.08 | -$4,254.12 | 120.58K |
Feb 14 - Feb 16
| |||
Form 4
| +8.94% | 9.35K |
$1.35 | -$5,610.60 | 113.89K |
Scheduled
|
Apr 27 - Oct 30
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
| +154.65% | 63.49K |
$3.15 | $199,999.80 | 104.55K |
Jul 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
| +155.72% | 25K |
—
|
—
| 41.05K |
Jan 26
| |||
Form 4
| +146.04% | 9.53K |
$5.75 | -$31,477.95 | 16.05K |
Jan 25 - Jan 28
| |||
Form 4
|
∞
| 6.53K |
$11.02 | -$38,294.50 | 6.53K |
Jan 26 - Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARIAD PHARMACEUTICALS INC No price found
EVP, General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 36.63K |
$5.03 | -$92,401.10 | 36.63K |
Feb 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CUBIST PHARMACEUTICALS INC No price found
EVP, Chief Legal
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -8.45K |
$102.00 | -$861,492.00 |
0
|
Jan 21
| |||
Form 4
| +1.89% | 148 |
$59.96 | $8,873.93 | 7.97K |
Dec 31
| |||
Form 4
| +329.14% | 6K |
$73.30 | -$381,251.88 | 7.82K |
Dec 29
| |||
Form 4
| +11.14% | 48 |
$66.34 | $3,184.32 | 479 |
Sep 30
| |||
Form 4
| +15.48% | 302 |
$63.85 | $18,539.86 | 2.25K |
Jun 30
| |||
Form 4
|
∞
| 1.61K |
$64.00 | -$49,152.08 | 1.61K |
Apr 15 - Apr 16
| |||
Form 4
| +32.56% | 84 |
$73.15 | $6,144.60 | 342 |
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
| +180.63% | 345 |
$55.73 | $16,455.28 | 536 |
Dec 31 - Dec 31
| |||
Form 4
| +94.90% | 93 |
$63.55 | $5,910.15 | 191 |
Sep 30
| |||
Form 4
|
∞
| 98 |
$48.29 | $4,732.42 | 98 |
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||